Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2019-04-24 Proxy Solicitation & In…
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
MAJOR TRANSACTION ACQUISITION OF 21% OF EQUITY INTEREST AND DEBT INTEREST IN ZHONGSHAN YUHONG REAL ESTATE DEVELOPMENT LIMITED
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by Overseas Chinese Town (Asia) Holdings Limited regarding a major transaction involving the acquisition of 21% equity interest and debt interest in Zhongshan Yuhong Real Estate Development Limited. It includes detailed information such as definitions, a letter from the board, terms of the cooperation agreement, financial information appendices, accountants' report, management discussion and analysis, unaudited pro forma financial information, and a valuation report. The document is comprehensive and provides substantive financial and transactional details related to the acquisition. It is not merely an announcement or a brief summary but a full circular intended for shareholders to inform them about the transaction and its implications. This type of document aligns with a Proxy Solicitation & Information Statement (PSI), which is typically a circular sent to shareholders to provide information and request votes for meetings related to major transactions or corporate actions. Therefore, the appropriate classification is PSI with high confidence.
2019-04-24 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2019
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/03/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised and issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on share capital changes and securities issuance, with no financial performance data, earnings, or management commentary. It is a regulatory filing reporting share capital movements and confirmations related to securities issuance, typical of a regulatory compliance report rather than a financial report or announcement of a report. Therefore, it fits best under the category of Regulatory Filings (RNS).
2019-04-04 English
PRELIMINARY ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
Annual Report Classification · 100% confidence The document is a detailed financial report containing audited consolidated results for the year ended 31 December 2018, including comprehensive financial statements such as the consolidated statement of profit or loss, other comprehensive income, and financial position. It references the application of Hong Kong Financial Reporting Standards (HKFRSs) and includes extensive financial data and notes on accounting policies and changes. The document is clearly a full annual financial report rather than a brief announcement or a presentation. Therefore, it fits the definition of an Annual Report (10-K). FY 2018
2019-03-31 English
MAJOR TRANSACTION ACQUISITION OF 21% OF EQUITY INTEREST AND DEBT INTEREST IN ZHONGSHAN YUHONG REAL ESTATE DEVELOPMENT LIMITED
M&A Activity Classification · 95% confidence The document is an announcement by Overseas Chinese Town (Asia) Holdings Limited regarding a major transaction involving the acquisition of 21% equity interest and debt interest in Zhongshan Yuhong Real Estate Development Limited. It details the cooperation agreement, parties involved, consideration, capital commitments, board composition, and reasons for the transaction. The announcement references compliance with Hong Kong Listing Rules, specifically Chapter 14, which governs major transactions. The document is lengthy (15,000 characters) and contains detailed transaction terms but does not present financial statements or quarterly/yearly financial results. It is not a report like an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a regulatory filing or certification. The content fits the category of a major transaction announcement related to acquisition activity, which aligns with the M&A Activity (TAR) category. Therefore, the document should be classified as M&A Activity (TAR).
2019-03-26 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Overseas Chinese Town (Asia) Holdings Limited regarding the date of a Board meeting to consider and approve the final results for the year ended 31 December 2018 and the payment of a final dividend. It does not contain any financial data or the actual report but merely announces the scheduling of the meeting where such results will be discussed. The document length is short (1483 characters) and fits the pattern of a meeting announcement rather than a full report. Therefore, it is not an Annual Report (10-K) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as a general announcement about corporate events that do not fit other categories.
2019-03-19 English
Monthly Return of Equity Issuer on Movement in Securities for the month ended 28 February 2019
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/02/2019, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content is focused on share capital changes and movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month. The document is about capital structure changes and share movements, which aligns with the category for Capital/Financing Update (CAP). The document length is over 14,000 characters, indicating it is a substantive report, not just an announcement or certification. Therefore, the best fitting classification is Capital/Financing Update (CAP).
2019-03-01 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.